1242329-23-2 Usage
General Description
3,5-Dibromo-4-chloro-pyridin-2-ylamine is a chemical compound belonging to the class of aminopyridines. It is an organic compound with the molecular formula C5H4Br2ClN2. 3,5-DibroMo-4-chloro-pyridin-2-ylaMine is commonly used as a building block in organic synthesis, particularly in the pharmaceutical industry for the development of various medications. Its chemical structure contains two bromine atoms and one chlorine atom attached to a pyridine ring, making it a halogenated aromatic amine. 3,5-Dibromo-4-chloro-pyridin-2-ylamine is considered to be a valuable intermediate in the synthesis of various chemical compounds and is an important component in the development of pharmaceutical products.
Check Digit Verification of cas no
The CAS Registry Mumber 1242329-23-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,4,2,3,2 and 9 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1242329-23:
(9*1)+(8*2)+(7*4)+(6*2)+(5*3)+(4*2)+(3*9)+(2*2)+(1*3)=122
122 % 10 = 2
So 1242329-23-2 is a valid CAS Registry Number.
1242329-23-2Relevant articles and documents
Synthesis and evaluation of the anticoccidial activity of trifluoropyrido[1,2-a]pyrimidin-2-one derivatives
Silpa, Laurence,Niepceron, Alisson,Laurent, Fabrice,Brossier, Fabien,Pénichon, Mélanie,Enguehard-Gueiffier, Cécile,Abarbri, Mohamed,Silvestre, Anne,Petrignet, Julien
supporting information, p. 114 - 120 (2015/12/18)
Screening of our chemical library to discover new molecules exhibiting in vitro activity against the invasion of host cells by Eimeria tenella revealed a lead compound with an IC50 of 15 μM. Structure-activity relationship studies were conducted with 34 newly synthesized compounds to identify more active molecules and enhance in vitro activity against the parasite. Four compounds were more effective in inhibiting MDBK cell invasion in vitro than the lead compound.
PYRIDINE DERIVATIVE
-
Page/Page column 31, (2012/02/04)
The present invention relates to a novel pyridine derivative or a pharmacologically acceptable ester thereof, or a pharmacologically acceptable salt of the derivative or ester, which has an excellent hypoglycemic effect or treats and/or prevents the onset
